HomeCompareAVGR vs EPRT

AVGR vs EPRT: Dividend Comparison 2026

AVGR yields 421.94% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AVGR wins by $164.3K in total portfolio value
10 years
AVGR
AVGR
● Live price
421.94%
Share price
$0.47
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$228.6K
Annual income
$477.83
Full AVGR calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — AVGR vs EPRT

📍 AVGR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAVGREPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AVGR + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AVGR pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVGR
Annual income on $10K today (after 15% tax)
$35,864.98/yr
After 10yr DRIP, annual income (after tax)
$406.16/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, EPRT beats the other by $10,789.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVGR + EPRT for your $10,000?

AVGR: 50%EPRT: 50%
100% EPRT50/50100% AVGR
Portfolio after 10yr
$146.5K
Annual income
$6,824.35/yr
Blended yield
4.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

AVGR
Analyst Ratings
4
Buy
3
Hold
Consensus: Buy
Altman Z
-48.2
Piotroski
4/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVGR buys
0
EPRT buys
0
No recent congressional trades found for AVGR or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAVGREPRT
Forward yield421.94%3.97%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%29%
Portfolio after 10y$228.6K$64.3K
Annual income after 10y$477.83$13,170.85
Total dividends collected$131.1K$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: AVGR vs EPRT ($10,000, DRIP)

YearAVGR PortfolioAVGR Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$31,797$21,097.05$11,212$512.01+$20.6KAVGR
2$65,370$31,346.90$12,689$692.09+$52.7KAVGR
3$100,060$30,114.17$14,521$944.30+$85.5KAVGR
4$128,604$21,539.72$16,841$1,302.88+$111.8KAVGR
5$150,543$12,936.60$19,841$1,821.64+$130.7KAVGR
6$168,157$7,076.40$23,818$2,587.47+$144.3KAVGR
7$183,622$3,693.63$29,230$3,744.65+$154.4KAVGR
8$198,360$1,884.73$36,816$5,540.38+$161.5KAVGR
9$213,196$951.40$47,806$8,413.17+$165.4KAVGR
10$228,598$477.83$64,324$13,170.85+$164.3KAVGR

AVGR vs EPRT: Complete Analysis 2026

AVGRStock

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.

Full AVGR Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this AVGR vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVGR vs SCHDAVGR vs JEPIAVGR vs OAVGR vs KOAVGR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.